Search results
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
Morningstar· 2 days agoGENEVA, SWITZERLAND / ACCESSWIRE / April 26, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF, RLFTY) (Relief Therapeutics ...
Altamira reports publication of positive results from NASAR clinical trial with Bentrio
Seeking Alpha· 4 days agoAltamira Therapeutics (CYTO) shares surge as positive results from the NASAR trial of their Bentrio nasal spray for allergic rhinitis are published.
...Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity...
Morningstar· 2 days agoSAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Akero Therapeutics ...
2 Fantastic Growth Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 3 days agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor returns as of April 22, 2024 Rachel Warren has no...
Short Interest in PainReform Ltd. (NASDAQ:PRFX) Increases By 232.9%
ETF DAILY NEWS· 3 days agoPainReform Ltd. (NASDAQ:PRFX – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 54,600 shares, a growth of 232.9% ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoNEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just...
CNBC· 5 days agoAfter a two-year dry spell, initial public offerings by biotech companies showed signs of life...
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary...
WCMH Columbus· 3 days agoCurrently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034. CBL-0201EFP Phase 2 study ...
